Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06352671 · ClinicalTrials.gov registry record
Prospective Long-Term Outcomes of a Standardized Ross Procedure
A clinical trial of Aortic Valve Disease, sponsored by Baylor Research Institute.
- Recruiting
- Registry status
- 225
- Enrollment target
- 1
- Study location
NCT06352671: Recruiting study of Aortic Valve Disease, sponsored by Baylor Research Institute.
NCT06352671 is a study of Aortic Valve Disease that is actively recruiting participants, run by Baylor Research Institute. The registered enrollment target is 225 participants, below the 18,602-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06352671, a study of Aortic Valve Disease, is actively recruiting participants, sponsored by Baylor Research Institute.
- RECRUITING
- Registry status
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
This standardized prospective long-term outcome analysis will help reaffirm these findings via a multicenter patient cohort and describe the best practices/techniques for stabilization of the autograft and right ventricular outflow tract reconstruction.
Primary Outcome
The primary endpoint of this study will be survival at 1-, 5-, and 10-year intervals.
Conditions Studied
Study Locations (1)
Texas
- Baylor Scott and White Heart Hospital - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2023-10-12 |
| Est. Completion | 2026-12-01 |
What NCT06352671 shows while recruiting
NCT06352671 is an observational study that tracks outcomes without assigning an intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 18,602-participant average among 15 other Aortic Valve Disease trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Aortic Valve Disease appearing as the primary indexed condition, and to 0 interventions.
NCT06352671 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06352671 about?
NCT06352671 is a clinical study titled "Prospective Long-Term Outcomes of a Standardized Ross Procedure". This standardized prospective long-term outcome analysis will help reaffirm these findings via a multicenter patient cohort and describe the best practices/techniques for stabilization of the autograft and right ventricular outflow tract reconstruction.
What is the current status of trial NCT06352671?
This trial is currently recruiting. The enrollment target is 225 participants. The study started on 2023-10-12. Estimated completion is 2026-12-01.
What conditions does trial NCT06352671 study?
This clinical trial studies the following conditions: Aortic Valve Disease.
Who is sponsoring clinical trial NCT06352671?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06352671 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aortic Valve Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06352671's enrollment target sits among peer trials
225 6th of 15 higher than 10 of 15 other Aortic Valve Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aortic Valve Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The JenaValve ALIGN-AR LVAD Registry
RECRUITING · NA
-
Quantification of Debris Captured Using TCEP During VIV TAVR With BVF
RECRUITING · NA
-
Valved Graft PMCF Study
RECRUITING
-
CardioHeartConnect: Commercially Available Fitness for Cardiac Rehabilitation
RECRUITING · NA
-
SJM Masters HP 15mm Rotatable Mechanical Heart Valve as Aortic Valve Replacement Therapy
ACTIVE NOT RECRUITING
-
Avalus Ultra Post-Approval Study (PAS)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI